Lv5
976 积分 2025-12-22 加入
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
3天前
已完结
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
8天前
已完结
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
9天前
已完结
Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease
9天前
已完结
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
9天前
已完结
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
10天前
已完结
Association of Epigenetic Aging Biomarkers With Risk of MASLD ‐Related HCC
10天前
已完结
AgentClinic: a multimodal benchmark for tool-using clinical AI agents
1个月前
已完结
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
1个月前
已完结
Risk stratification of a novel non-invasive fibrosis score in metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
皖公网安备34019202002308
